FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023211060> ?p ?o ?g. }

• W2023211060 endingPage "152" @default.
• W2023211060 startingPage "139" @default.
• W2023211060 abstract "The aim of this study was to evaluate the efficacy and tolerability of hormone replacement therapy (HRT) among postmenopausal women living in the Lund area of Southern Sweden and to analyze treatment effects in different types or routes of HRT administration, as well as to compare with unopposed estrogen therapy.in an ongoing, large population-based, prospective cohort study, this interim analysis included 3900 women. Of them, 693 postmenopausal women were eligible in the present analyses as they continued to use one of the four commercial HRT products for at least 2-3 years, i.e. continuous oral estradiol (E(2)) 2 mg+norethisterone acetate (NETA) 1 mg (CON-O), sequential oral estradiol 2 mg + norethisterone acetate 1 mg (CYC-O), sequential transdermal estradiol 50 microg + norethisterone acetate 250 microg (CYC-TRANS) and estradiol monotherapy. These women completed one generic questionnaire and one specific 'hormonal' questionnaire, as well as a personal interview pertaining to socio-demographics, detailed status of HRT use, and therapeutic efficacy and untoward side-effects by HRT.comparing the three combined E(2)+NETA groups with E(2) monotherapy, the beneficial effects on sexual desire and emotional well-being were significantly less in the combined groups than in E(2) monotherapy group. There was no significant difference regarding the negative side-effects between the groups. No significant difference was found between CON-O and CYC-O groups either in positive effects or in negative side-effects. A higher prevalence of positive effects was found in CYC-TRANS group than that in CYC-O group, especially in amelioration of sleep and urinary symptoms. Higher odd ratios of negative effects by HRT, such as irregular bleeds, weight gain, food craving and skin disorders were also found in CYC-TRANS group.in long-term HRT administration, the addition of a progestogen in HRT could compromise the beneficial effects of estradiol, particularly, the effects on women's emotional well being and psychosexual functioning. Administration of NETA continuously and sequentially had similar therapeutic efficacy and tolerability. More marked positive effects, such as improving of sleep and urinary symptoms, as well as nuisance side-effects, i.e. irregular bleeds, weight gain, food craving and skin disorders were encountered by the women using sequential transdermal regimen" @default.
• W2023211060 created "2016-06-24" @default.
• W2023211060 creator A5000592357 @default.
• W2023211060 creator A5031167487 @default.
• W2023211060 creator A5054341149 @default.
• W2023211060 creator A5055728459 @default.
• W2023211060 creator A5059661783 @default.
• W2023211060 creator A5061076693 @default.
• W2023211060 creator A5087556944 @default.
• W2023211060 date "2000-08-01" @default.
• W2023211060 modified "2023-09-26" @default.
• W2023211060 title "Effects of norethisterone acetate addition to estradiol in long term HRT" @default.
• W2023211060 cites W1452220229 @default.
• W2023211060 cites W1486945093 @default.
• W2023211060 cites W1549372639 @default.
• W2023211060 cites W1604937352 @default.
• W2023211060 cites W1963886401 @default.
• W2023211060 cites W1964322624 @default.
• W2023211060 cites W1972143280 @default.
• W2023211060 cites W1976447270 @default.
• W2023211060 cites W1988052347 @default.
• W2023211060 cites W1989131241 @default.
• W2023211060 cites W1996659292 @default.
• W2023211060 cites W1996671713 @default.
• W2023211060 cites W2000949555 @default.
• W2023211060 cites W2003956195 @default.
• W2023211060 cites W2009632476 @default.
• W2023211060 cites W2014035121 @default.
• W2023211060 cites W2025054705 @default.
• W2023211060 cites W2036378567 @default.
• W2023211060 cites W2052917111 @default.
• W2023211060 cites W2058788943 @default.
• W2023211060 cites W2082571940 @default.
• W2023211060 cites W2089752745 @default.
• W2023211060 cites W2094008928 @default.
• W2023211060 cites W2094829770 @default.
• W2023211060 cites W2134262258 @default.
• W2023211060 cites W3022017015 @default.
• W2023211060 cites W4230457936 @default.
• W2023211060 cites W4230677126 @default.
• W2023211060 cites W4242175523 @default.
• W2023211060 cites W4321429430 @default.
• W2023211060 doi "https://doi.org/10.1016/s0378-5122(00)00146-8" @default.
• W2023211060 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11006501" @default.
• W2023211060 hasPublicationYear "2000" @default.
• W2023211060 type Work @default.
• W2023211060 sameAs 2023211060 @default.
• W2023211060 citedByCount "17" @default.
• W2023211060 countsByYear W20232110602016 @default.
• W2023211060 countsByYear W20232110602022 @default.
• W2023211060 countsByYear W20232110602023 @default.
• W2023211060 crossrefType "journal-article" @default.
• W2023211060 hasAuthorship W2023211060A5000592357 @default.
• W2023211060 hasAuthorship W2023211060A5031167487 @default.
• W2023211060 hasAuthorship W2023211060A5054341149 @default.
• W2023211060 hasAuthorship W2023211060A5055728459 @default.
• W2023211060 hasAuthorship W2023211060A5059661783 @default.
• W2023211060 hasAuthorship W2023211060A5061076693 @default.
• W2023211060 hasAuthorship W2023211060A5087556944 @default.
• W2023211060 hasConcept C126322002 @default.
• W2023211060 hasConcept C188816634 @default.
• W2023211060 hasConcept C197934379 @default.
• W2023211060 hasConcept C205679159 @default.
• W2023211060 hasConcept C2777164284 @default.
• W2023211060 hasConcept C2778375690 @default.
• W2023211060 hasConcept C2779279991 @default.
• W2023211060 hasConcept C2780159708 @default.
• W2023211060 hasConcept C2780835420 @default.
• W2023211060 hasConcept C2781039349 @default.
• W2023211060 hasConcept C2908647359 @default.
• W2023211060 hasConcept C29456083 @default.
• W2023211060 hasConcept C2986817661 @default.
• W2023211060 hasConcept C71924100 @default.
• W2023211060 hasConcept C72563966 @default.
• W2023211060 hasConcept C98274493 @default.
• W2023211060 hasConcept C99454951 @default.
• W2023211060 hasConceptScore W2023211060C126322002 @default.
• W2023211060 hasConceptScore W2023211060C188816634 @default.
• W2023211060 hasConceptScore W2023211060C197934379 @default.
• W2023211060 hasConceptScore W2023211060C205679159 @default.
• W2023211060 hasConceptScore W2023211060C2777164284 @default.
• W2023211060 hasConceptScore W2023211060C2778375690 @default.
• W2023211060 hasConceptScore W2023211060C2779279991 @default.
• W2023211060 hasConceptScore W2023211060C2780159708 @default.
• W2023211060 hasConceptScore W2023211060C2780835420 @default.
• W2023211060 hasConceptScore W2023211060C2781039349 @default.
• W2023211060 hasConceptScore W2023211060C2908647359 @default.
• W2023211060 hasConceptScore W2023211060C29456083 @default.
• W2023211060 hasConceptScore W2023211060C2986817661 @default.
• W2023211060 hasConceptScore W2023211060C71924100 @default.
• W2023211060 hasConceptScore W2023211060C72563966 @default.
• W2023211060 hasConceptScore W2023211060C98274493 @default.
• W2023211060 hasConceptScore W2023211060C99454951 @default.
• W2023211060 hasIssue "2" @default.
• W2023211060 hasLocation W20232110601 @default.
• W2023211060 hasLocation W20232110602 @default.
• W2023211060 hasOpenAccess W2023211060 @default.
• W2023211060 hasPrimaryLocation W20232110601 @default.

• next